Byron Lawson is SVP/Chief Commercial Officer of HTG MOLECULAR DIAGNOSTICS, INC. Currently has a direct ownership of 6,033 shares of HTGM, which is worth approximately $2,051. The most recent transaction as insider was on Dec 09, 2022, when has been sold 1,000 shares (Common Stock) at a price of $0.42 per share, resulting in proceeds of $420. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.03K
0% 3M change
0% 12M change
Total Value Held $2,051

Byron Lawson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 09 2022
BUY
Grant, award, or other acquisition
$420 $0.42 p/Share
1,000 Added 14.22%
6,033 Common Stock
Jun 30 2022
SELL
Payment of exercise price or tax liability
$24 $1.03 p/Share
23 Reduced 0.45%
5,033 Common Stock
Jun 10 2022
BUY
Grant, award, or other acquisition
$480 $0.48 p/Share
1,000 Added 16.51%
5,056 Common Stock
Mar 31 2022
SELL
Payment of exercise price or tax liability
$32 $1.39 p/Share
23 Reduced 0.56%
4,056 Common Stock
Dec 31 2021
SELL
Payment of exercise price or tax liability
$130 $5.42 p/Share
24 Reduced 0.58%
4,079 Common Stock
Dec 10 2021
BUY
Grant, award, or other acquisition
$3,190 $3.56 p/Share
896 Added 17.92%
4,103 Common Stock
Sep 30 2021
SELL
Payment of exercise price or tax liability
$137 $5.71 p/Share
24 Reduced 0.74%
3,207 Common Stock
Jun 30 2021
SELL
Payment of exercise price or tax liability
$139 $5.81 p/Share
24 Reduced 0.74%
3,231 Common Stock
Jun 10 2021
BUY
Grant, award, or other acquisition
$1,388 $3.92 p/Share
354 Added 9.81%
3,255 Common Stock
Mar 31 2021
SELL
Payment of exercise price or tax liability
$153 $5.47 p/Share
28 Reduced 0.96%
2,901 Common Stock
Dec 31 2020
SELL
Payment of exercise price or tax liability
$115 $4.79 p/Share
24 Reduced 0.81%
2,929 Common Stock
Dec 10 2020
BUY
Grant, award, or other acquisition
$321 $4.87 p/Share
66 Added 2.19%
2,953 Common Stock
Sep 30 2020
SELL
Payment of exercise price or tax liability
$116 $0.33 p/Share
350 Reduced 0.8%
43,333 Common Stock
BL

Byron Lawson

SVP/Chief Commercial Officer
Tucson, AZ

Track Institutional and Insider Activities on HTGM

Follow HTG MOLECULAR DIAGNOSTICS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HTGM shares.

Notify only if
Any

Insider Trading

Get notified when an Htg Molecular Diagnostics, Inc insider buys or sells HTGM shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to HTG MOLECULAR DIAGNOSTICS, INC

Track Activities on HTGM